2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
37
Unknown
23
Recruiting
5
Not yet recruiting
5
Active not recruiting
5
Terminated
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Interventions
Specimen Handling
31
Magnetic Resonance Spectroscopy
19
Biopsy
16
Cyclophosphamide
15
Nivolumab
10
Paclitaxel
9
Vincristine
8
Cisplatin
8
venetoclax
7
Prednisone
7
Gemcitabine
7
Doxorubicin
7
Bevacizumab
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Surgical Procedures, Operative
5
Rituximab
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Injections
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
Taxes
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Hepatectomy
×
Clear all
NCT04840186
2024-11-12
EXCALIBUR3
Oslo University Hospital
Phase 2
Suspended
62 enrolled